Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				18 and over				Other				KMUH-IRB-960044 NCT00630084


2.		STI571 ProspectIve RandomIzed Trial: SPIRIT

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				030482 NCT00219739


3.		Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other				SHEBA-06-4015-IH-CTIL NCT00297570


4.		Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 60				Other				DSMM V NCT00546988


5.		Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other, Pharmaceutical / Industry				2007-0450 NCT00791271

Last Modified: 9/30/2008 First Published: 7/1/2002


6.		Phase II Study of Pegylated Interferon alfa After Radiotherapy in Children With Diffuse Pontine Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				NCI				NCI-02-C-0193 NCT00041145


7.		Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				NCI, Other				MEL06 NCT00539591


8.		Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				18 and over				Other				CD-2007-01 NCT00610389


9.		A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				Other				EC 1942-02 HARECCTR0500039, NCT00563095

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute